Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate CAS 152628-01-8 Puritas >99.0% (HPLC) Telmisartan Intermedia Factory
Ruifu Chemical Supple Telmisartan intermedia Cum Puritate
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl) Acidum benzoicum CAS 7148-03-0
Telmisartan Benzimidazole Acidum CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Nomen chemicum | Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate |
Synonyma | Telmisartan Impuritas 31;3-Methyl-4-Butyrylamido-5-Nitro Benzoic Acidum Methyl Ester;4-Butyrylamino-3-methyl-5-nitrobenzoicum Acidum Methyl Ester |
CAS Number | 152628-01-8 |
CATTUS Number | RF-PI1881 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C13H16N2O5 |
M. Pondus | 280.28 |
Liquescens punctum | 151.0~153.0℃ |
Density | 1.265 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba pulveris |
Puritas / Analysis Methodus | >99.0% (HPLC) |
Damnum in Siccatio | <1.00% |
Residere in Ignition | <0.50% |
Totalis immunditias | <1.00% |
Metalla gravia (ut Pb) | <20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Telmisartanum (CAS: 144701-48-4) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate (CAS: 152628-01-8) utilis est media synthetica in productione Telmisartanae (CAS: 144701-48-4), medicamentum antihypertensivum.Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate est pars efficacioris processus synthesisendi Telmisartanae secundum immunditiam, cedem, sumptus et magnarum productionis.Telmisartan est angiotensin II receptaculum obstructorem (ARB) indicatum pro: Curatio hypertensionis, pressura sanguinis inferioris.Pressio sanguinis demissio periculum minuit eventus cardiovasculares fatales et nonfatales, imprimis ictus et infarctiones myocardiales.Periculum reductionis in inhibitores aegros ACE inhibitores cardiovasculares (CV) capere non possunt.